OCTREOTIDE ACETATE LONG ACTING RELEASE INJECTION 20MG - (MEDIZIA TIDE 20 INJECTION)

Short Description
Octreotide Acetate Long Acting Release Injection 20mg is a sustained release formulation designed for controlled medicine delivery under specialist supervision, manufactured with strict quality standards for reliable supply, dependable quality.
Category
ONCOLOGY RANGE
Packing Size
Packing Type
Description

OCTREOTIDE ACETATE LONG ACTING RELEASE INJECTION 20MG – Third Party Manufacturing

Medizia Biotech is a trusted pharmaceutical company offering Third Party Manufacturing services for Octreotide Acetate Long Acting Release Injection 20mg across India. Manufactured in WHO-GMP compliant facilities, our product is produced under stringent quality standards to ensure safety, efficacy, and consistency.

We provide comprehensive contract manufacturing solutions including product manufacturing, quality assurance, customized packaging, private labeling, and timely nationwide delivery. Whether you are a pharma company, hospital supplier, institutional buyer, or distributor, Medizia Biotech offers flexible manufacturing options, including small batch production and bulk quantities to suit your business requirements.

Our experienced team ensures complete regulatory compliance, competitive pricing, reliable supply chain management, and dedicated customer support throughout the manufacturing process. With advanced production facilities and strict quality control, Medizia Biotech has become a preferred partner for third party pharmaceutical manufacturing.

Partner with Medizia Biotech for Octreotide Acetate Long Acting Release Injection 20mg Third Party Manufacturing and expand your product portfolio with confidence through a trusted pharmaceutical manufacturing company.

Ophthalmic

Eye and Ear Drops